Integrative analysis of transcriptional regulatory network and copy number variation in intrahepatic cholangiocarcinoma

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Li, Ling ^a,b   Lian, Baofeng ^b,c   Li, Chao ^d   Li, Wei ^b   Li, Jing ^b   Zhang, Yuannv ^d   He, Xianghuo ^d   Li, Yixue ^a,c,d   Xie, Lu ^b  

^a TONGJI UNIVERSITY   (China)

^b SHANGHAI CENTER FOR BIOINFORMATION TECHNOLOGY   (China)

^c SHANGHAI JIAO TONG UNIVERSITY   (China)

^d Chinese Academy of Sciences   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BILE DUCT CARCINOMA; BIOENGINEERING; BIOLOGICAL ACTIVITY; CANCER CLASSIFICATION; CANCER PATIENT; CLUSTER ANALYSIS; COPY NUMBER VARIATION; GENE EXPRESSION PROFILING; GENE REGULATORY NETWORK; GENETIC DISORDER; GENETIC SCREENING; GENOMICS; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; TRANSCRIPTIONAL REGULATORY NETWORK; BILE DUCT TUMOR; BIOLOGY; CHROMOSOME ABERRATION; GENE EXPRESSION REGULATION; GENETICS; HUMAN; INTRAHEPATIC BILE DUCT; METABOLISM; NUCLEIC ACID DATABASE; PROCEDURES; WNT SIGNALING PATHWAY;

TRANSFORMING GROWTH FACTOR BETA;

BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CHOLANGIOCARCINOMA; CHROMOSOME ABERRATIONS; CLUSTER ANALYSIS; COMPUTATIONAL BIOLOGY; DATABASES, NUCLEIC ACID; DNA COPY NUMBER VARIATIONS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE REGULATORY NETWORKS; HUMANS; MAP KINASE SIGNALING SYSTEM; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA; WNT SIGNALING PATHWAY;

EID: 84902492630     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0098653     Document Type: Article

References (57)

1. Blais A, Dynlacht BD (2005) Constructing transcriptional regulatory networks. Genes & development 19: 1499-1511. (Pubitemid 41002994)
2. Baum B, Craig G (2004) RNAi in a postmodern, postgenomic era. Oncogene 23: 8336-8339. (Pubitemid 39540713)
3. Cartharius K, Frech K, Grote K, Klocke B, Haltmeier M, et al. (2005) MatInspector and beyond: promoter analysis based on transcription factor binding sites. Bioinformatics 21: 2933-2942. (Pubitemid 40916416)
4. Yu H, Tu K, Wang Y-J, Mao J-Z, Xie L, et al. (2012) Combinatorial network of transcriptional regulation and microRNA regulation in human cancer. BMC systems biology 6: 61.
5. Neph S, Stergachis AB, Reynolds A, Sandstrom R, Borenstein E, et al. (2012) Circuitry and dynamics of human transcription factor regulatory networks. Cell 150: 1274-1286.
6. Zeng L, Yu J, Huang T, Jia H, Dong Q, et al. (2012) Differential combinatorial regulatory network analysis related to venous metastasis of hepatocellular carcinoma. BMC genomics 13: S14.
7. Beckmann JS, Estivill X, Antonarakis SE (2007) Copy number variants and genetic traits: closer to the resolution of phenotypic to genotypic variability. Nature Reviews Genetics 8: 639-646. (Pubitemid 47077281)
8. Curtis C, Shah SP, Chin S-F, Turashvili G, Rueda OM, et al. (2012) The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. Nature 486: 346-352.
9. Xu Y, DuanMu H, Chang Z, Zhang S, Li Z, et al. (2012) The application of gene co-expression network reconstruction based on CNVs and gene expression microarray data in breast cancer. Molecular biology reports 39: 1627-1637.
10. Villard J (2004) Transcription regulation and human diseases. Swiss medical weekly 134: 571-579.
11. Muller PA, Vousden KH, Norman JC (2011) p53 and its mutants in tumor cell migration and invasion. The Journal of cell biology 192: 209-218.
12. Green DR, Kroemer G (2009) Cytoplasmic functions of the tumour suppressor p53. Nature 458: 1127-1130.
13. McCulley DJ, Black BL (2012) Transcription factor pathways and congenital heart disease. Current topics in developmental biology 100: 253.
14. Essaghir A, Demoulin J-B (2012) A minimal connected network of transcription factors regulated in human tumors and its application to the quest for universal cancer biomarkers. PloS one 7: e39666.
15. Sia D, Tovar V, Moeini A, Llovet J (2013) Intrahepatic cholangiocarcinoma: pathogenesis and rationale for molecular therapies. Oncogene 32: 4861-4870.
16. Sia D, Hoshida Y, Villanueva A, Roayaie S, Ferrer J, et al. (2013) Integrative molecular analysis of intrahepatic cholangiocarcinoma reveals 2 classes that have different outcomes. Gastroenterology 144: 829-840.
17. Workman C, Jensen LJ, Jarmer H, Berka R, Gautier L, et al. (2002) A new nonlinear normalization method for reducing variability in DNA microarray experiments. Genome biol 3: 1-16.
18. Bunn AG (2008) A dendrochronology program library in R (dplR). Dendrochronologia 26: 115-124.
19. Olshen AB, Venkatraman E, Lucito R, Wigler M (2004) Circular binary segmentation for the analysis of array-based DNA copy number data. Biostatistics 5: 557-572. (Pubitemid 41180205)
20. Reich M, Liefeld T, Gould J, Lerner J, Tamayo P, et al. (2006) GenePattern 2.0. Nature genetics 38: 500-501.
21. Xu H, Yu H, Tu K, Shi Q, Wei C, et al. (2013) cGRNB: a web server for building combinatorial gene regulatory networks through integrated engineering of seed-matching sequence information and gene expression datasets. BMC Systems Biology 7: S7.
22. Meyer PE, Lafitte F, Bontempi G (2008) minet: AR/Bioconductor package for inferring large transcriptional networks using mutual information. BMC bioinformatics 9: 461.
23. Zhang JD, Wiemann S (2009) KEGGgraph: a graph approach to KEGG PATHWAY in R and bioconductor. Bioinformatics 25: 1470-1471.
24. Smoot ME, Ono K, Ruscheinski J, Wang P-L, Ideker T (2011) Cytoscape 2.8: new features for data integration and network visualization. Bioinformatics 27: 431-432.
25. Devarajan K (2008) Nonnegative matrix factorization: an analytical and interpretive tool in computational biology. PLoS computational biology 4: e1000029.
26. Homayounfar K, Gunawan B, Cameron S, Haller F, Baumhoer D, et al. (2009) Pattern of chromosomal aberrations in primary liver cancers identified by comparative genomic hybridization. Human pathology 40: 834-842.
27. Uhm K-O, Park Y-N, Lee J-Y, Yoon D-S, Park S-H (2005) Chromosomal imbalances in Korean intrahepatic cholangiocarcinoma by comparative genomic hybridization. Cancer genetics and cytogenetics 157: 37-41. (Pubitemid 40164856)
28. Demichelis F, Setlur SR, Banerjee S, Chakravarty D, Chen JYH, et al. (2012) Identification of functionally active, low frequency copy number variants at 15q21. 3 and 12q21. 31 associated with prostate cancer risk. Proceedings of the National Academy of Sciences 109: 6686-6691.
29. Pylkäs K, Vuorela M, Otsukka M, Kallioniemi A, Jukkola-Vuorinen A, et al. (2012) Rare copy number variants observed in hereditary breast cancer cases disrupt genes in estrogen signaling and TP53 tumor suppression network. PLoS genetics 8: e1002734.
30. Huang T, Liu L, Liu Q, Ding G, Tan Y, et al. (2011) The role of Hepatitis C Virus in the dynamic protein interaction networks of hepatocellular cirrhosis and carcinoma. International journal of computational biology and drug design 4: 5-18.
31. Mudduluru G, Vajkoczy P, Allgayer H (2010) Myeloid zinc finger 1 induces migration, invasion, and in vivo metastasis through Axl gene expression in solid cancer. Molecular Cancer Research 8: 159-169.
32. Gao H, Chakraborty G, Lee-Lim AP, Mo Q, Decker M, et al. (2012) The BMP inhibitor Coco reactivates breast cancer cells at lung metastatic sites. Cell 150: 764-779.
33. Sun Q, Wang Y, Zhang Y, Liu F, Cheng X, et al. (2007) Expression profiling reveals dysregulation of cellular cytoskeletal genes in HBx-induced hepatocarcinogenesis. CANCER BIOLOGY AND THERAPY 6: 668.
34. Zhai Y, Zhou G, Deng G, Xie W, Dong X, et al. (2006) Estrogen receptor α polymorphisms associated with susceptibility to hepatocellular carcinoma in hepatitis B virus carriers. Gastroenterology 130: 2001-2009. (Pubitemid 43816947)
35. Blechacz B, Komuta M, Roskams T, Gores GJ (2011) Clinical diagnosis and staging of cholangiocarcinoma. Nature Reviews Gastroenterology and Hepatology 8: 512-522.
36. Kiesslich T, Alinger B, Wolkersdörfer GW, Ocker M, Neureiter D, et al. (2010) Active Wnt signalling is associated with low differentiation and high proliferation in human biliary tract cancer in vitro and in vivo and is sensitive to pharmacological inhibition. International journal of oncology 36: 49-58.
37. Rodríguez-Molinero A, López-Diéguez M, Banegas JR (2007) Tissue homeostasis and cancer. Medical hypotheses 68: 1333-1341. (Pubitemid 46498436)
38. Tan FLS, Ooi A, Huang D, Wong JC, Qian CN, et al. (2010) p38delta/MAPK13 as a diagnostic marker for cholangiocarcinoma and its involvement in cell motility and invasion. International Journal of Cancer 126: 2353-2361.
39. Sirica AE (2008) Role of ErbB family receptor tyrosine kinases in intrahepatic cholangiocarcinoma. World journal of gastroenterology: WJG 14: 7033.
40. Geynisman DM, Catenacci DV (2012) Toward personalized treatment of advanced biliary tract cancers. Discovery medicine 14: 41-57.
41. Hodgson P, Aich P, Manuja A, Hokamp K, Roche F, et al. (2005) Effect of stress on viral-bacterial synergy in bovine respiratory disease: novel mechanisms to regulate inflammation. Comparative and functional genomics 6: 244-250. (Pubitemid 40797023)
42. Sakurai H (2012) Targeting of TAK1 in inflammatory disorders and cancer. Trends in pharmacological sciences 33: 522-530.
43. Dudeja V, Mujumdar N, Phillips P, Chugh R, Borja-Cacho D, et al. (2009) Heat shock protein 70 inhibits apoptosis in cancer cells through simultaneous and independent mechanisms. Gastroenterology 136: 1772-1782.
44. Rane MJ, Song Y, Jin S, Barati MT, Wu R, et al. (2010) Interplay between Akt and p38 MAPK pathways in the regulation of renal tubular cell apoptosis associated with diabetic nephropathy. American Journal of Physiology-Renal Physiology 298: F49-F61.
45. Aksamitiene E, Kiyatkin AB, Kholodenko BN (2012) Cross-talk between mitogenic Ras/MAPK and survival PI3K/Akt pathways: a fine balance.
46. Stone JC (2011) Regulation and function of the RasGRP family of Ras activators in blood cells. Genes & cancer 2: 320-334.
47. Narong S, Leelawat K (2011) Basic fibroblast growth factor induces cholangiocarcinoma cell migration via activation of the MEK1/2 pathway. Oncol Lett 2: 821-825.
48. Gozdecka M, Breitwieser W (2012) The roles of ATF2 (activating transcription factor 2) in tumorigenesis. Biochemical Society Transactions 40: 230-234.
49. Zhang K-S, Zhou Q, Wang Y-F, Liang L-J (2013) Inhibition of Wnt signaling induces cell apoptosis and suppresses cell proliferation in cholangiocarcinoma cells. Oncology reports 30: 1430-1438.
50. Nagayama S, Yamada E, Kohno Y, Aoyama T, Fukukawa C, et al. (2009) Inverse correlation of the up-regulation of FZD10 expression and the activation of β-catenin in synchronous colorectal tumors. Cancer Science 100: 405-412.
51. Fritz G, Kaina B (2006) Rho GTPases: promising cellular targets for novel anticancer drugs. Current cancer drug targets 6: 1-14.
52. Ling Q, Dong F, Geng L, Liu Z, Xie H, et al. (2013) Impacts of TCF7L2 gene polymorphisms on the susceptibility of hepatogenous diabetes and hepatocellular carcinoma in cirrhotic patients. Gene 522: 214-218.
53. Munker S, Liu Y, Meyer C, Dooley S, Li J, et al. (2012) TGF-β1 contributes to intrahepatic cholangiocarcinoma via Smad dependent and independent pathways. Zeitschrift für Gastroenterologie 50 - P5-40.
54. Huang Q, Liu L, Liu C-H, Shao F, Xie F, et al. (2012) Expression of Smad7 in cholangiocarcinoma: prognostic significance and implications for tumor metastasis. Asian Pac J Cancer Prev 13: 5161-5165.
55. Yuan W, Huang T, Yu J, Zeng L, Lian B, et al. (2014) Comparative analysis of viral protein interaction networks in Hepatitis B Virus and Hepatitis C Virus infected HCC. Biochimica et Biophysica Acta (BBA)-Proteins and Proteomics 1844: 271-279.
56. Liu Q, Tan Y, Huang T, Ding G, Tu Z, et al. (2010) TF-centered downstream gene set enrichment analysis: Inference of causal regulators by integrating TFDNA interactions and protein post-translational modifications information. BMC bioinformatics 11: S5.
57. Zaman N, Li L, Jaramillo ML, Sun Z, Tibiche C, et al. (2013) Signaling network assessment of mutations and copy number variations predict breast cancer subtype-specific drug targets. Cell reports 5: 216-223.